The lungs are covered by a thin serous layer (the visceral pleura). The pleura is then reflected on to the chest wall and pericardium (the parietal pleura). The lung hila 'connect' the visceral and parietal pleura. There is normally a small amount of fluid in the 'pleural space' between the parietal and visceral pleura, which lubricates movement between them. A pleural effusion occurs when the volume of this fluid is substantially greater than normal.
Examination
See separate Respiratory System History and Examination article. If the effusion is small, there may be no abnormality on examination.
Inspection -note:
Any evidence of loss of weight or underlying malignancy. Nicotine staining on the fingers. Finger clubbing. Rheumatoid changes in the hands. Whether the patient is dyspnoeic. Whether accessory muscles of respiration are being used. If the effusion is unilateral and large -there will be reduced movement on that side of the chest.
Palpation -chest expansion is reduced on the side of the effusion. Feel for deviation of the trachea. With a large unilateral effusion it is displaced away from the lesion. If there is associated collapse, the trachea is deviated towards the lesion. Mediastinal shift suggests an effusion that is in excess of a litre. There may be decreased tactile vocal fremitus.
Percussion -an effusion will cause stony dullness on percussion. Laterally, it may rise up towards the axilla. Auscultation -breath sounds are diminished or absent over an effusion. Vocal resonance is lost over a pleural effusion except at its upper surface (this is called aegophony -it sounds like a goat bleating).
Investigations CXR: this is the first investigation if a pleural effusion is suspected clinically. [11] PA film will usually suffice and, rarely, lateral views are needed. About 200 ml of fluid is required to be visible on a PA view but just 50 ml will cause costophrenic blunting on a lateral view.
Bilateral effusions with an enlarged heart shadow are commonly caused by congestive cardiac failure. Pleural plaques and calcifications may be seen, suggesting history of asbestos exposure.
Further initial investigations include ultrasound, CT scans, MRI and pleural fluid analysis. [12] Ultrasound is much more sensitive than CXRs for detecting pleural effusions and can detect even very small effusions. [13] 
Unilateral pleural effusion
The British Thoracic Society (BTS) suggests a diagnostic algorithm for the investigation of a unilateral pleural effusion. [6] This is outlined below: 
Wait for the results of the pleural aspiration:
If the fluid analysis and chemical features have not given a diagnosis, referral to a chest physician should be made. They can then commence further investigations including:
CT of the thorax ± abdomen: usually carried out with contrast enhancement. This should be done before the effusion is drained and it has a high sensitivity for malignant pleural disease. [7] It can also show abdominal malignancy.
Pleural biopsy: samples should be sent for histology and TB culture; in mesothelioma, the biopsy site should be irradiated to stop biopsy site invasion by tumour. This can either be blind biopsy using an Abram's needle, CT-guided biopsy or biopsy performed at the time of thoracoscopy.
Repeat pleural aspiration: special tests for rheumatoid disease (glucose and complement) and pancreatitis (amylase) may also be added.
Thoracoscopy: this allows direct visualisation of the pleura and can allow tissue diagnosis, fluid drainage and pleurodesis. It can be performed under conscious sedation. [14] Bronchoscopy: BTS guidelines suggest that this investigation should be reserved for patients whose radiology suggests a mass or loss of volume or when there is a history of haemoptysis or possible foreign body aspiration.
Bilateral pleural effusion
The BTS suggests that 'aspiration should not be performed for bilateral effusions in a clinical setting strongly suggestive of a pleural transudate, unless there are atypical features or they fail to respond to therapy'. [6] Interpreting pleural fluid results
Transudate or exudate: the pleural protein content usually differentiates between a transudative and an exudative effusion.
Exudates have a protein level of >30 g/L; transudates have a protein level of <30 g/L.
If the pleural fluid protein is between 25 and 35 g/L, Light's criteria should be applied to differentiate transudates and exudates accurately. [6] Light's criteria state that the pleural fluid is an exudate if one or more of the following criteria are met: [5] Pleural fluid protein divided by serum protein >0.5. Pleural fluid LDH divided by serum LDH >0.6. Pleural fluid LDH more than two thirds the upper limits of normal serum LDH.
Bloody pleural fluid: bloody pleural fluid can be caused by:
Malignancy. Pulmonary embolus with infarction. Trauma. Benign asbestos pleural effusions. Post-cardiac injury syndrome.
Pleural fluid haematocrit:
if the pleural fluid is bloody, the haematocrit of the fluid should be measured. If the haematocrit of the pleural fluid is more than half of the patient's peripheral blood haematocrit, the patient has a haemothorax. If the haematocrit of the pleural fluid is <1%, the blood in the pleural fluid is not significant. [11] pH: pleural pH is mainly used to identify pleural infection. Normal pleural pH is about 7.6; a pH of <7.2 with a normal blood pH is found in: Pleural infection and empyema. Rheumatoid disease and systemic lupus erythematosus (SLE). TB. Malignancy. Oesophageal rupture.
Cytology: malignant effusions are diagnosed by pleural fluid cytology alone in only 60% of cases. [6] If the first pleural fluid cytology specimen is negative, it should be repeated.
Cholesterol, triglycerides, cholesterol crystals and chylomicrons:
Chylothorax usually has a triglyceride level >1.24 mmol/L, cholesterol <5.18 mmol/L, no cholesterol crystals and the presence of chylomicrons. Pseudochylothorax has a triglyceride level <0.56 mmol/L, cholesterol level >5.18 mmol/L, no chylomicrons and the presence of cholesterol crystals.
Glucose: causes of low pleural glucose levels (<3.3 mmol/L) are:
Empyema. Rheumatoid disease. SLE. TB. Malignancy. Oesophageal rupture.
Differential white cell counts: pleural lymphocytosis is common in malignancy and TB.
Management
Management should be aimed at the underlying disease. If a transudate is confirmed, aspiration should be avoided. Small effusions that are not causing respiratory embarrassment may be managed by observation. Tapping the fluid can give symptomatic relief as well as being useful for diagnosis but the effusion is likely to re-form. Repeated tapping may be used in palliative care. No more than 1.5 litres should be removed at a single procedure, as fluid shifts can result in pulmonary oedema. [15] In malignant effusions, if no attempt is made at pleurodesis, nearly all have recurred within a month.
A chest drain can also be inserted for controlled drainage of the effusion. The drain can be removed if/when the underlying disease has been treated. Chest drains are often needed for the management of empyema and haemothorax. Long-term indwelling pleural drainage may be used in some patients with malignant effusions.
Pleurectomy is also used in some cases of malignant effusion when other treatment options have failed. Surgically implanted pleuroperitoneal shunts are occasionally used for the treatment of malignant effusions and chylothorax.
Pleurodesis
This is injection of a sclerosant to cause adhesion of the visceral and parietal pleura and to help to prevent reaccumulation of the effusion. Sclerosing agents that are commonly used include tetracycline, sterile talc and bleomycin. It is most often used in the management of recurrent malignant effusions. For more detail on how to carry out the procedure, refer to the BTS guidelines for the management of malignant pleural effusions. [6] Prognosis This is dependent on the cause of the effusion. The presence of a malignant pleural effusion is associated with a poor prognosis with median survival following diagnosis ranging from 3 to 12 months depending on cell type. [1] Further reading & references
